- HZNP has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $133.2 million.
- HZNP has traded 101,816 shares today.
- HZNP is up 3.9% today.
- HZNP was down 6% yesterday.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in HZNP with the Ticky from Trade-Ideas. See the FREE profile for HZNP NOW at Trade-Ideas More details on HZNP: Horizon Pharma plc, a specialty biopharmaceutical company, engages in identifying, developing, acquiring or in-licensing, and commercializing medicines for the treatment of arthritis, pain, inflammatory, and/or orphan diseases in the United States and internationally. Currently there are 5 analysts that rate Horizon Pharma a buy, no analysts rate it a sell, and none rate it a hold. The average volume for Horizon Pharma has been 3.9 million shares per day over the past 30 days. Horizon has a market cap of $3.6 billion and is part of the health care sector and drugs industry. The stock has a beta of 2.15 and a short float of 8% with 1.76 days to cover. Shares are up 121.3% year-to-date as of the close of trading on Thursday.